Bank of New York Mellon’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,569
Closed -$23.1K 4225
2025
Q4
$23.1K Hold
4,569
﹤0.01% 4160
2025
Q3
$47.2K Hold
4,569
﹤0.01% 4133
2025
Q2
$38.4K Hold
4,569
﹤0.01% 4096
2025
Q1
$42.4K Hold
4,569
﹤0.01% 4060
2024
Q4
$103K Hold
4,569
﹤0.01% 4031
2024
Q3
$171K Hold
4,569
﹤0.01% 3946
2024
Q2
$171K Hold
4,569
﹤0.01% 3974
2024
Q1
$154K Sell
4,569
-285
-6% -$10.3K ﹤0.01% 3986
2023
Q4
$194K Hold
4,854
﹤0.01% 3963
2023
Q3
$154K Hold
4,854
﹤0.01% 4022
2023
Q2
$162K Hold
4,854
﹤0.01% 4022
2023
Q1
$216K Sell
4,854
-1,281
-21% -$103K ﹤0.01% 3887
2022
Q4
$464K Sell
6,135
-1,788
-23% -$167K ﹤0.01% 3572
2022
Q3
$762K Buy
7,923
+478
+6% +$66.9K ﹤0.01% 3337
2022
Q2
$1.25M Sell
7,445
-163
-2% -$24.8K ﹤0.01% 3098
2022
Q1
$1.41M Buy
7,608
+1,401
+23% +$290K ﹤0.01% 3112
2021
Q4
$1.66M Buy
6,207
+521
+9% +$137K ﹤0.01% 3106
2021
Q3
$1.66M Buy
5,686
+764
+16% +$223K ﹤0.01% 3101
2021
Q2
$1.22M Sell
4,922
-263
-5% -$67.6K ﹤0.01% 3289
2021
Q1
$1.48M Buy
5,185
+193
+4% +$77K ﹤0.01% 3098
2020
Q4
$1.39M Buy
4,992
+1,670
+50% +$619K ﹤0.01% 3053
2020
Q3
$1.35M Buy
3,322
+16
+0.5% +$8.22K ﹤0.01% 2928
2020
Q2
$1.92M Buy
3,306
+2,877
+671% +$1.31M ﹤0.01% 2711
2020
Q1
$98K Buy
+429
New +$74.4K ﹤0.01% 3865

Other funds holding CODX

Bank of New York Mellon's CODX Position: Q1 2026 in Review

Bank of New York Mellon sold out of Co-Diagnostics (CODX) in Q1 2026, closing a stake of 4,569 shares — an estimated $23.1K sold.

Bank of New York Mellon first reported a position in CODX in Q1 2020 and held it in 24 quarters. The position peaked at $1.92M in Q2 2020. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.

  • Bank of New York Mellon reported no remaining Co-Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Bank of New York Mellon sold 4,569 Co-Diagnostics shares in Q1 2026, an estimated $23.1K.
  • Bank of New York Mellon first reported a position in Co-Diagnostics in Q1 2020 and held it in 24 quarters.
  • Bank of New York Mellon's Co-Diagnostics position peaked at $1.92M in Q2 2020.
  • 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.

Based on Bank of New York Mellon's 13F filing for Q1 2026, filed 5 May 2026.